Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Bure Equity AB ( (SE:BURE) ) just unveiled an update.
Bure Equity AB reported a decrease in net asset value by 16.5% in the first half of 2025, with significant investment activities including acquiring a 17% stake in Silex Microsystems, a leader in MEMS foundry services. The company faced mixed performance from its portfolio companies, with notable growth in Mycronic and a significant order for Ovzon, while others like Vitrolife and Xvivo experienced challenges. The acquisition of Silex is seen as a strategic move to enhance growth opportunities amid geopolitical complexities.
More about Bure Equity AB
Bure Equity AB is an investment company focusing on long-term ownership and development of companies in various industries. It has a diversified portfolio that includes companies in technology, healthcare, and industrial sectors.
Average Trading Volume: 64,687
Technical Sentiment Signal: Sell
Current Market Cap: SEK20.88B
Learn more about BURE stock on TipRanks’ Stock Analysis page.